🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sunitinib shows anti-tumor activity in a variety of human non-small cell lu...
Status
Unknown
Location
Section of Hematology, Department of Medicine,Taipei Medical University Hospital
Start Date
2009-01
Trial ID
NCT01019798
Treatments Being Tested
The purpose of this study is to determine whether Sunitinib and Docetaxel i...
Status
Completed
Location
Samsung Medical Center
Start Date
2008-11
Trial ID
NCT01238055
Treatments Being Tested
This is a multi-center, open-label, Phase 1/2 study of SU011248 (sunitinib ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-10
Trial ID
NCT00137436
Treatments Being Tested
The major goal is to determine whether the experimental agent has clinicall...
Status
Unknown
Location
Tom Baker Cancer Centre
Start Date
2007-10
Trial ID
NCT00550810
Treatments Being Tested
This study aims to find out whether the effect of docetaxel chemotherapy ma...
Status
Unknown
Location
National University Hospital
Start Date
2013-05
Trial ID
NCT01803503
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Hematology Oncology Associates
Start Date
2007-03
Trial ID
NCT00599313
Treatments Being Tested
This study will compare the safety and efficacy of sunitinib in combination...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2008-07
Trial ID
NCT00676650
Treatments Being Tested
This study will aims to determine the maximum tolerated dose of CGC-11047 w...
Status
Completed
Location
Rocky Mountain Cancer Centre
Start Date
2006-05
Trial ID
NCT00705874
This study is determining the maximum tolerated dose and safety of SU011248...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-07
Trial ID
NCT00712504
The purpose of this study is to compare progression free survival for SU011...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-01
Trial ID
NCT00246571
Treatments Being Tested